CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-29 | Funicular Fund, LP See Footnote 1 | Purchase | +8,974 | $2.30 | $21K | 2,226,325 |
| 2022-04-28 | Funicular Fund, LP See Footnote 1 | Purchase | +23,381 | $2.32 | $54K | 2,217,351 |
| 2022-04-25 | Funicular Fund, LP See Footnote 1 | Purchase | +13,751 | $2.29 | $32K | 2,193,970 |
| 2022-04-25 | Funicular Fund, LP See Footnote 1 | Sale · Put Option (obligation to buy) | −7,500 | $64.00 | $480K | 14,500 |
| 2022-04-19 | Funicular Fund, LP See Footnote 1 | Sale · Put Option (obligation to buy) | −7,000 | $64.00 | $448K | 7,000 |
| 2022-04-18 | Funicular Fund, LP See Footnote 1 | Purchase | +9,119 | $2.31 | $21K | 2,180,219 |
Page 18 of 18 · 346 trades